Fulton Bank decreased Abbvie Inc (ABBV) stake by 9.83% reported in 2017Q3 SEC filing. Fulton Bank sold 8,108 shares as Abbvie Inc (ABBV)’s stock rose 6.17%. The Fulton Bank holds 74,376 shares with $6.61M value, down from 82,484 last quarter. Abbvie Inc now has $154.39B valuation. The stock decreased 1.10% or $1.08 during the last trading session, reaching $96.71. About 3.21 million shares traded. AbbVie Inc. (NYSE:ABBV) has risen 10.63% since January 1, 2017 and is uptrending. It has underperformed by 6.07% the S&P500.
Among 11 analysts covering Kohlberg Kravis Roberts & Co. (NYSE:KKR), 8 have Buy rating, 0 Sell and 3 Hold. Therefore 73% are positive. Kohlberg Kravis Roberts & Co. has $31 highest and $14 lowest target. $22.46’s average target is 6.65% above currents $21.06 stock price. Kohlberg Kravis Roberts & Co. had 46 analyst reports since July 28, 2015 according to SRatingsIntel. Wood maintained KKR & Co. L.P. (NYSE:KKR) rating on Monday, July 11. Wood has “Market Perform” rating and $20 target. The firm earned “Buy” rating on Tuesday, June 6 by Jefferies. As per Thursday, September 24, the company rating was maintained by Oppenheimer. On Thursday, September 10 the stock rating was maintained by Citigroup with “Buy”. As per Tuesday, August 9, the company rating was maintained by Barclays Capital. The firm has “Hold” rating given on Sunday, August 9 by Standpoint Research. The firm has “Buy” rating given on Thursday, October 26 by Oppenheimer. As per Tuesday, August 2, the company rating was maintained by Jefferies. The firm has “Buy” rating by Keefe Bruyette & Woods given on Monday, August 14. On Monday, May 29 the stock rating was maintained by Keefe Bruyette & Woods with “Buy”. See KKR & Co. L.P. (NYSE:KKR) latest ratings:
26/10/2017 Broker: Oppenheimer Rating: Buy New Target: $28.0 Maintain
19/10/2017 Broker: Jefferies Rating: Buy New Target: $23.0 Maintain
16/10/2017 Broker: Goldman Sachs Rating: Buy New Target: $24.0 Upgrade
05/10/2017 Broker: Morgan Stanley Rating: Equal-Weight Old Target: $20 New Target: $21 Maintain
28/09/2017 Broker: Keefe Bruyette & Woods Rating: Buy New Target: $25.0 Maintain
18/09/2017 Broker: Jefferies Rating: Buy New Target: $23.0 Maintain
14/08/2017 Broker: Keefe Bruyette & Woods Rating: Buy New Target: $25.0 Maintain
08/08/2017 Broker: Morgan Stanley Rating: Equal-Weight Old Target: $19 New Target: $20 Maintain
27/07/2017 Broker: Oppenheimer Rating: Buy Maintain
14/07/2017 Broker: Oppenheimer Rating: Outperform Old Target: $26 New Target: $27 Maintain
Investors sentiment decreased to 0.97 in Q3 2017. Its down 0.11, from 1.08 in 2017Q2. It turned negative, as 32 investors sold KKR & Co. L.P. shares while 84 reduced holdings. 28 funds opened positions while 84 raised stakes. 286.80 million shares or 0.90% more from 284.23 million shares in 2017Q2 were reported. Gabelli & Com Inv Advisers has 120,410 shares. First Allied Advisory Serv, a Missouri-based fund reported 61,920 shares. Provise Mgmt Group Ltd owns 0.03% invested in KKR & Co. L.P. (NYSE:KKR) for 10,215 shares. Quinn Opportunity Prtnrs Limited Liability Co has invested 0.88% in KKR & Co. L.P. (NYSE:KKR). Gamco Et Al has invested 0.03% of its portfolio in KKR & Co. L.P. (NYSE:KKR). Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Inv Mngmt has 0.01% invested in KKR & Co. L.P. (NYSE:KKR). Alabama-based Kistler has invested 0.02% in KKR & Co. L.P. (NYSE:KKR). Ls Invest Advsrs Limited Liability Corp stated it has 18,010 shares or 0.02% of all its holdings. Franklin Resources invested in 12,410 shares. Td Asset Management Incorporated reported 0.05% in KKR & Co. L.P. (NYSE:KKR). Fifth Third State Bank invested in 2,800 shares. Texas Yale Cap accumulated 81,000 shares or 0.14% of the stock. National Asset Mgmt holds 26,585 shares or 0.09% of its portfolio. Cambridge Inv Advsrs owns 50,554 shares. Keybank National Association Oh has 20,434 shares for 0% of their portfolio.
KKR & Co. L.P. is a private equity and real estate investment firm specializing in direct and fund of fund investments in fintech sector. The company has market cap of $17.22 billion. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, and middle market investments. It has a 10.61 P/E ratio. The firm considers investments in all industries with a focus on software, security, semiconductors, consumer electronics, internet of things , internet, information services, information technology infrastructure, network and cyber security architecture, engineering and operations, content, technology and hardware, energy and infrastructure, real estate, services industry with a focus on business services, intelligence, industry-leading franchises and companies in natural resource, containers and packaging, agriculture, airports, ports, forestry, electric utilities, textiles, apparel and luxury goods, household durables, digital media, insurance, brokerage houses, non-durable goods distribution, supermarket retailing, grocery stores, food, beverage, and tobacco, hospitals, entertainment venues and production companies, publishing, printing services, capital goods, financial services, specialized finance, pipelines, and renewable energy.
The stock decreased 0.33% or $0.07 during the last trading session, reaching $21.06. About 980,528 shares traded. KKR & Co. L.P. (NYSE:KKR) has risen 43.92% since January 1, 2017 and is uptrending. It has outperformed by 27.22% the S&P500.
Since July 31, 2017, it had 0 insider buys, and 8 sales for $45.57 million activity. GONZALEZ RICHARD A also sold $6.24 million worth of AbbVie Inc. (NYSE:ABBV) on Thursday, August 3. 300 shares were sold by Gosebruch Henry O, worth $21,127. On Thursday, December 14 the insider Schumacher Laura J sold $14.07M. SALEKI-GERHARDT AZITA had sold 8,300 shares worth $705,655. On Monday, December 18 the insider RICHMOND TIMOTHY J. sold $8.57M. Michael Robert A. sold $589,512 worth of stock.
Among 21 analysts covering Abbvie Inc (NYSE:ABBV), 11 have Buy rating, 1 Sell and 9 Hold. Therefore 52% are positive. Abbvie Inc has $110.0 highest and $6 lowest target. $77.11’s average target is -20.27% below currents $96.71 stock price. Abbvie Inc had 69 analyst reports since July 21, 2015 according to SRatingsIntel. BMO Capital Markets maintained the stock with “Market Perform” rating in Thursday, November 16 report. The stock of AbbVie Inc. (NYSE:ABBV) earned “Hold” rating by BMO Capital Markets on Friday, April 28. As per Tuesday, December 5, the company rating was maintained by Leerink Swann. On Thursday, July 20 the stock rating was maintained by Credit Suisse with “Hold”. SunTrust maintained AbbVie Inc. (NYSE:ABBV) on Sunday, October 29 with “Buy” rating. As per Wednesday, June 7, the company rating was maintained by BMO Capital Markets. The stock of AbbVie Inc. (NYSE:ABBV) earned “Outperform” rating by Leerink Swann on Monday, October 2. Citigroup upgraded AbbVie Inc. (NYSE:ABBV) on Monday, September 28 to “” rating. The stock has “Hold” rating by BMO Capital Markets on Wednesday, April 19. The company was maintained on Wednesday, October 11 by BMO Capital Markets.
Analysts await AbbVie Inc. (NYSE:ABBV) to report earnings on January, 26. They expect $1.43 earnings per share, up 19.17% or $0.23 from last year’s $1.2 per share. ABBV’s profit will be $2.28 billion for 16.91 P/E if the $1.43 EPS becomes a reality. After $1.41 actual earnings per share reported by AbbVie Inc. for the previous quarter, Wall Street now forecasts 1.42% EPS growth.
Fulton Bank increased Harris Assoc Invt Tr stake by 200,504 shares to 1.41M valued at $40.64M in 2017Q3. It also upped Ingersoll (NYSE:IR) stake by 3,677 shares and now owns 15,611 shares. Cummins Inc (NYSE:CMI) was raised too.